Glenmark Life Sciences Profit & Loss Annual

Trade
BSE: 543322 | NSE: GLS | ISIN: INE03Q201024 | Sector: Biotechnology & Drugs
850.05 -10.25 (-1.19%)Updated : 14 Jun 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 2,283.219,481.518,458.357,844.13
Total Revenue 2,283.219,481.518,458.357,844.13
Costof Revenue Total 1,002.016,100.205,956.235,420.15
Gross Profit 1,281.203,381.322,502.122,423.98
Selling/ General/ Admin Expenses Total 258.16795.54736.11547.68
Depreciation/ Amortization 53.45245.65281.63227.09
Other Operating Expenses Total 348.8025.4623.7117.02
Total Operating Expense 1,662.427,166.856,999.026,211.94
Operating Income 620.792,314.661,459.331,632.19
Interest Inc( Exp) Net- Non- Op Total -15.46-3,519.15-3,201.04-2,645.41
Other Net 12.04-17.83-40.46-33.10
Net Income Before Taxes 631.291,952.341,098.841,331.10
Provisionfor Income Taxes 160.40497.91266.93376.27
Net Income After Taxes 470.891,454.43831.91954.83
Net Income Before Extra Items 470.891,454.43831.91954.83
Net Income 470.891,454.43831.91954.83
Income Availableto Com Excl Extra Ord 470.891,454.43831.91954.83
Income Availableto Com Incl Extra Ord 470.891,454.43831.91954.83
Diluted Net Income 470.891,454.43831.91954.83
Diluted Weighted Average Shares 12.279.679.679.70
Diluted EPS Excluding Extra Ord Items 38.38150.4286.0498.48
Diluted Normalized EPS 38.38149.8586.1498.73
Unusual Expense( Income) -0.001.33-
Gain( Loss)on Saleof Assets -74.170.72-34.45
Minority Interest -0.000.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,927.00+62.95(2.20%)
3,533.75+62.00(1.79%)
1,597.45+16.55(1.05%)
1,370.95-19.15 (-1.38%)
HomeMarketsPremiumInstant LoanGet App